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OBJECTIVES We studied the relation between changes in systolic blood pressure and RR interval during
downward tilting in comparison with assessment of baroreflex sensitivity (BRS) measured by
the phenylephrine method (Phe-BRS) and with measures of heart rate variability (HRV).
BACKGROUND The method most extensively used for assessing BRS involves bolus injections of phenyleph-
rine. Several noninvasive methods proposed to assess BRS have not been widely applied in the
clinical setting.
METHODS Sixteen healthy male volunteers were studied (mean age 6 SD 27.5 6 4.6 years). Arterial
blood pressure using tonometry and electrocardiogram was simultaneously recorded. After
20 min of 70° upright tilting, the table was returned to supine position at a speed of 3.2°/s.
Subsequently, BRS was assessed using an intravenous bolus injection of phenylephrine (2 to
3 mg/kg). Heart rate variability under resting conditions also was analyzed.
RESULTS In all subjects, a beat to beat systolic blood pressure increase associated with corresponding
RR interval lengthening was observed during downward tilting as well as during phenyleph-
rine administration. During both testing procedures, these two variables showed linear
correlation, and the slope of regression line during downward tilting (DT-BRS) correlated
significantly with Phe-BRS (r 5 0.79, p 5 0.0003). The DT- and Phe-BRS also correlated
significantly with the high frequency component of resting HRV (r 5 0.70, p 5 0.0023 for
DT-BRS; r 5 0.58, p 5 0.0185 for Phe-BRS).
CONCLUSIONS We conclude that in a small homogeneous group DT-BRS provided an assessment of reflex
cardiac vagal function comparable to that obtained by the phenylephrine method. (J Am Coll
Cardiol 1999;34:211–5) © 1999 by the American College of Cardiology
Baroreflex sensitivity (BRS) has been reported to identify
patients with increased risk of life-threatening ventricular
tachyarrhythmias and sudden death after myocardial infarc-
tion (1–5). The method most extensively described for
assessing BRS involves bolus intravenous injections of
phenylephrine (1–6). The phenylephrine method of BRS
assessment (Phe-BRS) has been reported to be safe and well
tolerated with no major complications (1–5), but nonethe-
less requires intravenous administration of the pressor agent.
Recently, several noninvasive methods have been proposed
for quantifying BRS (7–13). However, they have not been
widely applied clinically (14).
The head-up tilt test has been shown to be useful in
assessing patients referred for recurrent unexplained syn-
cope. In such testing, we have noted during the return of the
table to the supine position from the upright posture a
dynamic beat to beat increase in systolic blood pressure in
association with an increase in the corresponding RR
interval, similar to observations after phenylephrine admin-
istration. We therefore hypothesized that assessment of the
baroreflex response to the downward tilting (DT-BRS) can
serve as a noninvasive index of reflex cardiac vagal function.
In the present study, therefore, we compared DT-BRS with
Phe-BRS as well as measures of resting heart rate variability
(HRV) in healthy young men.
METHODS
Subjects. We studied 16 healthy men (20 to 38-years-old;
mean age 6 SD 27.5 6 4.6 years). A detailed medical
history and examination excluded the evidence of any
organic disease. None of the 16 subjects had a history of
vasovagal fainting. None was taking medication and all were
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nonsmokers. Written informed consent was obtained from
all subjects. The study was approved by our institution’s
review board.
Study protocol. All subjects were studied in the fasting
state at rest. Studies were performed in a quiet room with
dimmed lights between 9 and 11 AM. Each patient was
placed on an electrically driven tilt table. A right cubital
venous catheter was placed, and arterial blood pressure was
recorded noninvasively using tonometry (Jentow-7700, Ni-
hon Colin, Komaki, Japan). The tonometric sensor was
attached over the left radial artery. To keep the level of heart
and the tonometric sensor equal during tilting, the left arm
was held horizontal and supported by a plate secured to the
table. The accuracy of continuous blood pressure monitor-
ing using this system has been demonstrated previously
(15). Arterial blood pressure and the standard 12-lead
electrocardiogram (ECG) were monitored simultaneously,
and data were stored in a PCM data recorded (RD-200T,
TEAC, Tokyo, Japan). Three-lead precordial Holter ECG
recordings (model-459, Del Mar Avionics, Irvine, Califor-
nia) also were obtained throughout the procedure for
analysis of HRV.
After waiting 30 min to permit cardiovascular baroreflex
mechanisms to achieve a steady state (1,3–5), subjects were
asked to breathe at a rate of 15 breaths/min using a
metronome, to maximize regularity between the respiratory
and the cardiovascular systems. After recording arterial
blood pressure and 12-lead ECG for 10 min, passive
upward tilting from 0° to 70° was performed and maintained
for 20 min. Thereafter, the table was returned to the supine
position at a speed of 3.2°/s. Fifteen minutes after comple-
tion of downward tilting, at which time the heart rate and
blood pressure had returned to steady state levels, BRS was
assessed by the phenylephrine method as previously de-
scribed (6). The drug (2 to 3 mg/kg) was injected over 15 s
to obtain a 15- to 40-mm Hg systolic blood pressure
increase. Baroreflex sensitivity measured by the phenyleph-
rine method was calculated as the slope of the linear
regression line relating systolic blood pressure changes to
RR interval changes. Regression lines with more than 20
data points and a correlation coefficient (r) greater than 0.8
were accepted for analysis. The phenylephrine injection was
repeated three times and the mean of the three slopes was
taken as the BRS value. Baroreflex sensitivity measured by
the downward tilting method was calculated as the slope of
the linear regression line relating systolic blood pressure
changes to RR interval changes during downward tilting.
Regression lines with more than 12 data points and r greater
than 0.8 were accepted for analysis.
Heart rate variability. Heart rate variability was analyzed
using a 300-s interval of Holter ECG recording beginning
10 min after the downward tilting. The power spectrum of
the RR intervals was computed by a fast Fourier transform
and expressed as the areas under the power spectrum (16).
Abbreviations and Acronyms
BRS 5 baroreflex sensitivity
DT-BRS 5 baroreflex sensitivity measured by the
downward tilting method
ECG 5 electrocardiogram
HF 5 high frequency (0.15 to 0.45 Hz)
HRV 5 heart rate variability
LF 5 low frequency (0.04 to 0.15 Hz)
Phe-BRS 5 baroreflex sensitivity measured by the
phenylephrine method
Figure 1. The relation between the changes in systolic blood
pressure increase and corresponding RR interval lengthening
observed in a 33-year old man during downward tilting. (A) Top
and middle panels: electrocardiographic tracing of V5 lead and
computed RR intervals. Bottom panel: arterial blood pressure
(BP) recorded with tonometry. Arrows indicate the beginning and
the end of downward tilting. (B) Plotting of corresponding RR
interval against systolic blood pressure in this subject revealed a
strong correlation (r 5 0.95; p , 0.0001), yielding a baroreflex
sensitivity value of 14.0 ms/mm Hg. ECG 5 electrocardiogram.
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We calculated the power of two spectral bands, a low
frequency component (LF) at 0.04 to 0.15 Hz and a high
frequency component (HF) at 0.15 to 0.40 Hz. The ratio of
LF to HF spectra (LF/HF) also was computed. Measured
values of HRV were transformed using a natural logarithm
because their distributions were skewed.
Statistical analysis. Data are presented as mean value 6
SD. Pearson product–moment correlation coefficient was
employed to compare how closely two variables were linearly
related (17). Correlation coefficients were tested for statis-
tical significance by means of t tests. Two correlation
coefficients were compared using a test procedure described
by Kleinbaum et al. (18). The method of Bland and Altman
(19) was used to determine limits of agreement between
Phe-BRS and DT-BRS. Limits of agreement were defined
as the mean difference in BRS 6 2 SD.
RESULTS
Changes in arterial blood pressure and RR interval
during downward tilting. None of the 16 subjects fainted
during 20 min of upright tilting. During downward tilting,
an increase in systolic blood pressure was observed in all 16
subjects (6 to 30 mm Hg, mean 6 SD, 15.1 6 6.1 mm Hg).
A significant linear correlation (r . 0.8) was observed
between systolic blood pressure increase and corresponding
RR interval lengthening in all 16 subjects, as illustrated for
a 33-year old man in Figure 1. In this subject, initiation of
downward tilting induced a beat to beat increase in systolic
blood pressure, reaching maximum approximately 20 s after
the beginning of this movement (bottom tracing in Fig.
1A). This increase in systolic blood pressure was accompa-
nied by an increase in the corresponding RR interval (top
and middle tracings in Fig. 1A). Plotting of corresponding
RR interval against systolic blood pressure in this subject
revealed a strong correlation (r 5 0.95, p , 0.0001; Fig.
1B), yielding a DT-BRS value of 14.0 ms/mm Hg. The
mean value of DT-BRS in the 16 subjects was 9.9 6 3.6
ms/mm Hg.
Comparison of DT-BRS with Phe-BRS. In all 16 sub-
jects, intravenous injection of phenylephrine caused a 15- to
40-mm Hg increase in systolic blood pressure showing a
significant linear correlation with lengthening of corre-
sponding RR interval. The mean value for Phe-BRS in the
16 subjects was 22.0 6 10.1 ms/mm Hg. The DT-BRS
correlated significantly with Phe-BRS (r 5 0.79, p 5
0.0003, Fig. 2). According to the analysis using the Bland-
Altman method, the mean difference in BRS as determined
by the two methods was 12.0 ms/mm Hg. The limits of
agreement were 23.2 to 27.2 ms/mm Hg.
Comparison of BRS with HRV. In 16 subjects studied,
both DT-BRS and Phe-BRS correlated significantly with
the power of HF but not with LF or LF/HF (Table 1).
DISCUSSION
Main findings. In the present study, we demonstrated a
strong correlation between systolic blood pressure increase
and corresponding RR interval lengthening during down-
ward tilting, which yielded DT-BRS values correlating well
with Phe-BRS. The DT-BRS values also correlated signif-
icantly with the HF component of resting HRV. Because
our present study was conducted in healthy individuals,
further investigation will be needed to determine whether
this noninvasive method has the same clinical predictive
value for major cardiac events as the phenylephrine method.
Previous assessments of BRS. The phenylephrine method
has been used extensively for BRS assessment (1–5). The
initially required invasive procedure for beat to beat arterial
blood pressure measurement has been overcome by the
availability of noninvasive methods of pressure monitoring
such as use of a Finapres device (14) or tonometry as
employed in the present study (15). The remaining disad-
vantages of the phenylephrine method involve the need for
intravenous administration of a pressor agent. Recently,
several noninvasive methods to assess BRS have been
Figure 2. The correlation between baroreflex sensitivity measured
by the downward tilting method (DT-BRS) and that by the
phenylephrine method (Phe-BRS) in 16 subjects studied; DT-
BRS correlated significantly with Phe-BRS (r 5 0.79; p 5
0.0003).
Table 1. Correlation of Baroreflex Sensitivity Measured by the
Downward Tilting or Phenylephrine Method With Frequency
Domain Analysis of Heart Rate Variability
r Value p Value
Downward tilting
ln HF power 0.70 0.0023
ln LF power 0.41 0.1149
LF/HF 0.08 0.7810
Phenylephrine
ln HF power 0.58 0.0185
ln LF power 0.32 0.2352
LF/HF 0.08 0.7660
HF 5 high frequency; LF 5 low frequency; HF and LF have been log transformed.
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advocated (7–13). The Valsalva maneuver and a neck
chamber technique have been reported to quantify the
baroreflex without using vasoactive drugs (7,8), but the
complexities of these techniques and of interpreting the
results have discouraged widespread clinical application of
these methods (14). Alternatively, spectral techniques have
been used to analyze the relationship between spontaneous
beat to beat oscillations of blood pressure and RR interval as
a way to quantify BRS (9,10). More recently, Hughson and
colleagues have advocated a method of studying the spon-
taneous baroreflex response using sequential beat by beat
analysis based on computer scanning of the ECG and
continuous noninvasive arterial pressure recordings from a
finger (11,12). In this method, a spontaneous baroreflex
response was defined as a series of at least three consecutive
heart beats in which systolic blood pressure and the subse-
quent RR interval either both increased or both decreased
(11,12). Both spectral analysis and the beat by beat sequence
methods are based on the assumption that baroreflexes do
not act only to control abrupt changes in arterial blood
pressure, but are continuously activated by small variations
of systolic arterial pressure. The gain of the spontaneous
baroreflex slope observed by these methods, however, indi-
cates minimal recruitment of cardiac vagal efferent neurons
by naturally occurring pressure variations. A recent study in
which spectral indexes were compared with the phenyleph-
rine method in patients with previous myocardial infarction
showed that despite a substantial linear correlation, agree-
ment between the vasoactive drug method and spectral
techniques in quantification of BRS was relatively weak
(20).
Baroreflex response to downward tilting. Baroreflex
mechanisms activated by downward tilting appear more
complex than those observed during phenylephrine admin-
istration. With the phenylephrine method, a vasocon-
striction-induced rise in blood pressure stimulates arterial
baroreceptors that cause activation of vagal efferent neurons
to result in RR interval lengthening. On the other hand, the
rise of blood pressure in response to downward tilting is
considered predominantly due to increased venous return
followed by an increase in cardiac output; these events
necessarily involve activation of cardiopulmonary barorecep-
tors in addition to arterial baroreceptors. Nevertheless, the
significant correlation of DT-BRS with Phe-BRS suggests
that the arterial baroreceptors may represent the predomi-
nant baroreflex component during downward tilting.
Whereas the gain of the phenylephrine-induced baroreflex
is an index of the maximum recruitment of cardiac vagal
efferent neurons during extremes of parasympathetic en-
gagement by very large pressure increases, baroreflex assess-
ment by downward tilting assesses relatively large but more
physiologic levels of recruitment of cardiac vagal efferent
neurons. In addition, whereas the phenylephrine test is
performed in a resting supine position, downward tilting is
initiated from a 70° upright posture in which sympathetic
activity is substantially increased (21). Thus, BRS assess-
ment during downward tilting measures baroreceptor sen-
sitivity during a sizable change in sympathetic tone. Resting
autonomic function in young, healthy subjects such as those
studied here differs from the situation in patients with heart
disease, who have substantial increased sympathetic tone
that can trigger potentially lethal arrhythmias. Accordingly,
the BRS assessment during downward tilting may be more
useful than the phenylephrine method because the tilting
method evaluates the baroreflex response in the setting of
increased sympathetic tone, a physiologic state that is likely
in patients with heart disease. Downward tilting does not
rely on pharmacologic stimuli and may provide more valu-
able BRS assessment in patient populations whose reflex
cardiac vagal activity requires clinical assessment. Further
study is needed to determine whether DT-BRS can provide
more useful information than Phe-BRS in patients with
heart disease.
Comparison with HRV. In the present study, DT-BRS
and Phe-BRS correlated significantly with the power of HF
in HRV. Heart rate variability has lacked strong correlation
with the Phe-BRS in normal patients (22) and in patients
with previous myocardial infarction (4), because measures of
HRV primarily reflect tonic vagal activity (4,22). In the
present study, HRV was assessed using only a 5-min
interval of ECG recording in healthy young men under
supine resting conditions. Considerable further study will be
needed to clarify the relationship between DT-BRS and
measures of HRV in patients with cardiovascular disease.
Study limitations. The present study has several limita-
tions. First, as already mentioned, we tested a relatively
small number of male subjects who were young and healthy;
Phe-BRS has been shown to correlate negatively with age
and to be decreased in patients with organic heart disease
(1–5). Prospective evaluation in larger and more varied
groups of patients will be necessary to confirm whether
DT-BRS generally correlates with Phe-BRS. Second, we
assessed DT-BRS only once in each subject; reproducibility
and day to day variability of the values obtained should be
tested. Third, 70° passive upright tilting maintained for
20 min was chosen, because our protocol was adopted from
that used in our department for diagnosis of patients with
unexplained syncope. The angle and duration for upright
tilting and the speed of downward tilting should be varied to
determine the optimal condition for BRS assessment.
Conclusions. We conclude that in a small homogeneous
group DT-BRS provided an assessment of reflex cardiac
vagal function comparable to that obtained by the phenyl-
ephrine method. The downward tilting method is noninva-
sive and safe, and may show promise for assessment of reflex
cardiac vagal activity in some patients with cardiovascular
disease.
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